These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8319626)

  • 1. Hemoglobin binding of aromatic amines: molecular dosimetry and quantitative structure-activity relationships for N-oxidation.
    Sabbioni G
    Environ Health Perspect; 1993 Mar; 99():213-6. PubMed ID: 8319626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationships for the N-oxidation.
    Sabbioni G
    Chem Biol Interact; 1992 Jan; 81(1-2):91-117. PubMed ID: 1730150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin binding of arylamines and nitroarenes: molecular dosimetry and quantitative structure-activity relationships.
    Sabbioni G
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):61-7. PubMed ID: 7889861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin binding of nitroarenes and quantitative structure-activity relationships.
    Sabbioni G
    Chem Res Toxicol; 1994; 7(2):267-74. PubMed ID: 8199317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin binding of bicyclic aromatic amines.
    Sabbioni G; Schütze D
    Chem Res Toxicol; 1998 May; 11(5):471-83. PubMed ID: 9585478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin adducts of N-substituted aryl compounds in exposure control and risk assessment.
    Neumann HG; Birner G; Kowallik P; Schütze D; Zwirner-Baier I
    Environ Health Perspect; 1993 Mar; 99():65-9. PubMed ID: 8319661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomonitoring of aromatic amines II: Hemoglobin binding of some monocyclic aromatic amines.
    Birner G; Neumann HG
    Arch Toxicol; 1988; 62(2-3):110-5. PubMed ID: 3196145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GC/MS analysis of biologically important aromatic amines. Application to human dosimetry.
    Stillwell WG; Bryant MS; Wishnok JS
    Biomed Environ Mass Spectrom; 1987 May; 14(5):221-7. PubMed ID: 2955825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Activity Relationships for Rates of Aromatic Amine Oxidation by Manganese Dioxide.
    Salter-Blanc AJ; Bylaska EJ; Lyon MA; Ness SC; Tratnyek PG
    Environ Sci Technol; 2016 May; 50(10):5094-102. PubMed ID: 27074054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-activity relationships of mutagenic aromatic and heteroaromatic azides and amines.
    Sabbioni G; Wild D
    Carcinogenesis; 1992 Apr; 13(4):709-13. PubMed ID: 1576721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of hemoglobin adducts from a 4, 4'-methylenedianiline metabolite evidently produced by peroxidative oxidation in vivo.
    Kautiainen A; Wachtmeister CA; Ehrenberg L
    Chem Res Toxicol; 1998 Jun; 11(6):614-21. PubMed ID: 9625729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sediment-associated reactions of aromatic amines. 2. QSAR development.
    Colón D; Weber EJ; Baughman GL
    Environ Sci Technol; 2002 Jun; 36(11):2443-50. PubMed ID: 12075802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomonitoring of aromatic amines V: acetylation and deacetylation in the metabolic activation of aromatic amines as determined by haemoglobin binding.
    Zwirner-Baier I; Neumann HG
    Arch Toxicol; 1998; 72(8):499-504. PubMed ID: 9765065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin Adducts and Urinary Metabolites of Arylamines and Nitroarenes.
    Sabbioni G
    Chem Res Toxicol; 2017 Oct; 30(10):1733-1766. PubMed ID: 28933159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of DNA adducts using HPLC/MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes.
    Jones CR; Sabbioni G
    Chem Res Toxicol; 2003 Oct; 16(10):1251-63. PubMed ID: 14565767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dosimetry of aromatic amines in human populations.
    Skipper PL; Tannenbaum SR
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):17-21. PubMed ID: 7889842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomonitoring of arylamines: haemoglobin adducts of aniline derivatives.
    Sabbioni AB
    Biomarkers; 1999; 4(3):229-36. PubMed ID: 23885865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemoglobin binding in control of exposure to and risk assessment of aromatic amines.
    Neumann HG
    IARC Sci Publ; 1988; (89):157-65. PubMed ID: 3198198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrolyzable hemoglobin adducts of polyfunctional monocyclic N-substituted arenes as dosimeters of exposure and markers of metabolism.
    Zwirner-Baier I; Kordowich FJ; Neumann HG
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):43-5. PubMed ID: 7889857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomonitoring of arylamines: hemoglobin adducts of urea and carbamate pesticides.
    Sabbioni G; Neumann HG
    Carcinogenesis; 1990 Jan; 11(1):111-5. PubMed ID: 2295119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.